HTG Molecular to Present Corporate Overview at the 8th Annual SVB Leerink Global Healthcare Conference

TUCSON, Ariz. , Feb. 20, 2019 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that TJ Johnson, Chief Executive Officer, will present a corporate overview the 8 th Annual SVB Leerink